Gastroenterology

Caris Diagnostics™ (a division Caris Life Sciences™) brings academic-caliber gastrointestinal (GI) pathology services to patients and their physicians with state-of-the-art laboratories, world-class physicians, and unsurpassed service. Caris is integrating new molecular technologies into daily practice and ensuring that physicians and patients have access to the most informative and relevant diagnostic information available.

Caris' GI pathologists are all subspecialty trained in gastrointestinal pathology, and include nationally known leaders in the field who hold and have held professorship positions at leading academic institutions such as Johns Hopkins, Harvard (Brigham and Women's and Beth Israel), Cleveland Clinic, Mayo Clinic, M.D. Anderson, Duke, Cornell, University of Texas, Memorial Sloan-Kettering Medical Center and many others. These distinguished pathologists have published over 1,500 peer-reviewed research studies and over 100 textbooks and book chapters, and regularly present research at the major national meetings for gastroenterologists and pathologists.

At Caris, an expert team carefully scrutinizes every biopsy under the microscope to render an accurate diagnosis for each patient. Caris also uses molecular testing to ensure the precision of these diagnoses to help guide the most appropriate treatment. The company's new colon cancer molecular profiling tool, Target Now Colon, combines a powerful array of tests to provide information that helps physicians and patients make better therapeutic choices. The company also employs techniques to identify which patients and families are at increased risk before cancer appears.

Caris is the world’s largest outpatient GI pathology practice, examining well over 2,500 GI biopsies every day. This unparalleled access to biopsy samples provides Caris' pathologists with unique research and learning opportunities to evaluate unusual cases as well as to characterize common diseases in ways not previously possible. The Caris commitment to ongoing learning is manifested through daily slide-review conferences, monthly didactic and journal review conferences, rigorous quality assurance, and continuous review of the company's diagnostic terminology and criteria.